Li Dean Y (CIK 0001837016)

Latest company ownership

Shares held
1,980,029
Last filed at
Oct 3, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
MRK - Merck & Co., Inc.
Role: President
Shares held
80,180.79
Last filed at
May 1, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 9, 2024 Feb 12, 2024 Merck & Co., Inc. President Sell 17.5 -14,702 -24.12% ✗ $1.8M
Jan 9, 2024 Jan 11, 2024 RECURSION PHARMACEUTICALS, INC. Director Sell 45.0 -29,000 -0.91% ✓ $396.2K
May 1, 2023 May 3, 2023 Merck & Co., Inc. President Sell 22.5 -524 -2.50% ✗ $60.5K
May 3, 2022 May 4, 2022 Merck & Co., Inc. President Sell 26.3 -381 -2.26% ✗ $33.4K
May 1, 2022 May 3, 2022 Merck & Co., Inc. President Sell 26.3 -523 -3.15% ✗ $46.4K
Dec 7, 2021 Dec 9, 2021 RECURSION PHARMACEUTICALS, INC. Director Sell 46.3 -15,900 -0.42% ✓ $325.6K
Nov 17, 2021 Dec 9, 2021 RECURSION PHARMACEUTICALS, INC. Director Sell 45.0 -19,100 -0.98% ✓ $385K
Nov 17, 2021 Nov 19, 2021 RECURSION PHARMACEUTICALS, INC. Director Sell 45.0 -19,100 -0.50% ✓ $385K
May 4, 2021 May 6, 2021 Merck & Co., Inc. President Sell 26.3 -238 -1.90% ✗ $18.1K
May 1, 2021 May 4, 2021 Merck & Co., Inc. President Sell 26.3 -611 -2.56% ✗ $45.5K